These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29599339)

  • 61. A reliable risk score for stage IV esophagogastric cancer.
    Blank S; Lordick F; Dobritz M; Grenacher L; Burian M; Langer R; Roth W; Schaible A; Becker K; Bläker H; Sisic L; Stange A; Compani P; Schulze-Bergkamen H; Jäger D; Büchler M; Siewert JR; Ott K
    Eur J Surg Oncol; 2013 Aug; 39(8):823-30. PubMed ID: 23375470
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Survival effect of neoadjuvant radiotherapy before esophagectomy for patients with esophageal cancer: a surveillance, epidemiology, and end-results study.
    Schwer AL; Ballonoff A; McCammon R; Rusthoven K; D'Agostino RB; Schefter TE
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):449-55. PubMed ID: 18538500
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Trends in esophageal cancer survival in United States adults from 1973 to 2009: A SEER database analysis.
    Njei B; McCarty TR; Birk JW
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1141-6. PubMed ID: 26749521
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Survival in lymph node negative adenocarcinoma of the esophagus after R0 resection with and without neoadjuvant therapy: evidence for downstaging of N status.
    Leers JM; Ayazi S; Hagen JA; Terterov S; Klipfel N; Oezcelik A; Abate E; Lipham JC; DeMeester SR; Banki F; DeMeester TR
    J Am Coll Surg; 2009 Apr; 208(4):553-6. PubMed ID: 19476789
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cyclo-oxygenase-2 expression in esophageal adenocarcinoma as a determinant of clinical outcome following esophagectomy.
    France M; Drew PA; Dodd T; Watson DI
    Dis Esophagus; 2004; 17(2):136-40. PubMed ID: 15230726
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Combined modality therapy of cT2N0M0 esophageal cancer: the University of Texas M. D. Anderson Cancer Center experience.
    Kountourakis P; Correa AM; Hofstetter WL; Lee JH; Bhutani MS; Rice DC; Komaki R; Maru DM; Ross WA; Vaporciyan A; Swisher SG; Ajani JA
    Cancer; 2011 Mar; 117(5):925-30. PubMed ID: 20960497
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Perineural invasion predicts for locoregional failure in patients with oesophageal adenocarcinoma treated with neoadjuvant chemoradiotherapy.
    Patel AK; Pan X; Vila DM; Frankel WL; Chen W; Perry KA; Merritt RE; D'Souza DM; Wuthrick EJ; Williams TM
    J Clin Pathol; 2021 Apr; 74(4):228-233. PubMed ID: 32317290
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Primary esophageal adenosquamous carcinoma: a retrospective analysis of 24 cases.
    Zhang HD; Chen CG; Gao YY; Ma Z; Tang P; Duan XF; Ren P; Yue J; Yu ZT
    Dis Esophagus; 2014; 27(8):783-9. PubMed ID: 24127755
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Impact of number and site of lymph node invasion on survival of adenocarcinoma of esophagogastric junction.
    Ielpo B; Pernaute AS; Elia S; Buonomo OC; Valladares LD; Aguirre EP; Petrella G; Garcia AT
    Interact Cardiovasc Thorac Surg; 2010 May; 10(5):704-8. PubMed ID: 20154347
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Primary Gross Tumor Volume is an Important Prognostic Factor in Locally Advanced Esophageal Cancer Patients Treated with Trimodality Therapy.
    Boggs DH; Hanna A; Burrows W; Horiba N; Suntharalingam M
    J Gastrointest Cancer; 2015 Jun; 46(2):131-7. PubMed ID: 25759174
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Supraclavicular node disease is not an independent prognostic factor for survival of esophageal cancer patients treated with definitive chemoradiation.
    Jeene PM; Versteijne E; van Berge Henegouwen MI; Bergmann JJ; Geijsen ED; van Laarhoven HW; Hulshof MC
    Acta Oncol; 2017 Jan; 56(1):33-38. PubMed ID: 27842455
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Proposed revision of the staging classification for esophageal cancer.
    Korst RJ; Rusch VW; Venkatraman E; Bains MS; Burt ME; Downey RJ; Ginsberg RJ
    J Thorac Cardiovasc Surg; 1998 Mar; 115(3):660-69; discussion 669-70. PubMed ID: 9535455
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparison of survival and prognostic factors in patients with gastric adenocarcinoma in T2 and T3.
    Jucá PC; Lourenço L; Kesley R; Mello EL; Oliveira IM; Correa JH
    Rev Col Bras Cir; 2012; 39(5):377-84. PubMed ID: 23174788
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Histopathologic findings predicting lymph node metastasis and prognosis of patients with superficial esophageal carcinoma: analysis of 240 surgically resected tumors.
    Tajima Y; Nakanishi Y; Ochiai A; Tachimori Y; Kato H; Watanabe H; Yamaguchi H; Yoshimura K; Kusano M; Shimoda T
    Cancer; 2000 Mar; 88(6):1285-93. PubMed ID: 10717608
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy.
    Chao YK; Chan SC; Liu YH; Chen HW; Wan YL; Chang HK; Fan KH; Liu HP
    Ann Surg; 2009 Mar; 249(3):392-6. PubMed ID: 19247024
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Treatment allocation in patients with early-stage esophageal adenocarcinoma: Prevalence and predictors of lymph node involvement.
    Gamboa AM; Kim S; Force SD; Staley CA; Woods KE; Kooby DA; Maithel SK; Luke JA; Shaffer KM; Dacha S; Saba NF; Keilin SA; Cai Q; El-Rayes BF; Chen Z; Willingham FF
    Cancer; 2016 Jul; 122(14):2150-7. PubMed ID: 27142247
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Multimodal treatment of locally advanced esophageal adenocarcinoma: which regimen should we choose? Outcome analysis of perioperative chemotherapy versus neoadjuvant chemoradiation in 105 patients.
    Hoeppner J; Zirlik K; Brunner T; Bronsert P; Kulemann B; Sick O; Marjanovic G; Hopt UT; Makowiec F
    J Surg Oncol; 2014 Mar; 109(3):287-93. PubMed ID: 24277235
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Extramural perineural invasion in pT3 and pT4 rectal adenocarcinoma as prognostic factor after preoperative chemoradiotherapy.
    Lino-Silva LS; Salcedo-Hernández RA; España-Ferrufino A; Ruiz-García EB; Ruiz-Campos M; León-Takahashi AM; Meneses-García A
    Hum Pathol; 2017 Jul; 65():107-112. PubMed ID: 28526604
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Tumor length as a prognostic factor in esophageal malignancy: univariate and multivariate survival analyses.
    Griffiths EA; Brummell Z; Gorthi G; Pritchard SA; Welch IM
    J Surg Oncol; 2006 Mar; 93(4):258-67. PubMed ID: 16496364
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Lymphovascular invasion as a tool to further subclassify T1b esophageal adenocarcinoma.
    Cen P; Hofstetter WL; Correa AM; Wu TT; Lee JH; Ross WA; Davilla M; Swisher SG; Fukami N; Rashid A; Maru D; Ajani JA
    Cancer; 2008 Mar; 112(5):1020-7. PubMed ID: 18205187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.